Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap

Clinical trial NCT01575756 · COMPLETED

Trial details

NCT number: NCT01575756
Sponsor: Octapharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Congenital Fibrinogen Deficiency Afibrinogenemia

Start date: 2013-06-01
Primary completion: 2015-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.